These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33915014)

  • 1. Supramolecular Cylinders Target Bulge Structures in the 5' UTR of the RNA Genome of SARS-CoV-2 and Inhibit Viral Replication*.
    Melidis L; Hill HJ; Coltman NJ; Davies SP; Winczura K; Chauhan T; Craig JS; Garai A; Hooper CAJ; Egan RT; McKeating JA; Hodges NJ; Stamataki Z; Grzechnik P; Hannon MJ
    Angew Chem Int Ed Engl; 2021 Aug; 60(33):18144-18151. PubMed ID: 33915014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supramolecular Cylinders Target Bulge Structures in the 5' UTR of the RNA Genome of SARS-CoV-2 and Inhibit Viral Replication.
    Melidis L; Hill HJ; Coltman NJ; Davies SP; Winczura K; Chauhan T; Craig JS; Garai A; Hooper CAJ; Egan RT; McKeating JA; Hodges NJ; Stamataki Z; Grzechnik P; Hannon MJ
    Angew Chem Weinheim Bergstr Ger; 2021 Aug; 133(33):18292-18299. PubMed ID: 38505190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion.
    Vora SM; Fontana P; Mao T; Leger V; Zhang Y; Fu TM; Lieberman J; Gehrke L; Shi M; Wang L; Iwasaki A; Wu H
    Proc Natl Acad Sci U S A; 2022 Mar; 119(9):. PubMed ID: 35149555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence.
    Tolksdorf B; Nie C; Niemeyer D; Röhrs V; Berg J; Lauster D; Adler JM; Haag R; Trimpert J; Kaufer B; Drosten C; Kurreck J
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A natural product compound inhibits coronaviral replication in vitro by binding to the conserved Nsp9 SARS-CoV-2 protein.
    Littler DR; Liu M; McAuley JL; Lowery SA; Illing PT; Gully BS; Purcell AW; Chandrashekaran IR; Perlman S; Purcell DFJ; Quinn RJ; Rossjohn J
    J Biol Chem; 2021 Dec; 297(6):101362. PubMed ID: 34756886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple rapid in vitro screening method for SARS-CoV-2 anti-virals that identifies potential cytomorbidity-associated false positives.
    Yan K; Rawle DJ; Le TT; Suhrbier A
    Virol J; 2021 Jun; 18(1):123. PubMed ID: 34107996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The rocaglate CR-31-B (-) inhibits SARS-CoV-2 replication at non-cytotoxic, low nanomolar concentrations in vitro and ex vivo.
    Müller C; Obermann W; Karl N; Wendel HG; Taroncher-Oldenburg G; Pleschka S; Hartmann RK; Grünweller A; Ziebuhr J
    Antiviral Res; 2021 Feb; 186():105012. PubMed ID: 33422611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metallo supramolecular cylinders inhibit HIV-1 TAR-TAT complex formation and viral replication in cellulo.
    Cardo L; Nawroth I; Cail PJ; McKeating JA; Hannon MJ
    Sci Rep; 2018 Sep; 8(1):13342. PubMed ID: 30190568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein.
    Panagiotopoulos A; Tseliou M; Karakasiliotis I; Kotzampasi DM; Daskalakis V; Kesesidis N; Notas G; Lionis C; Kampa M; Pirintsos S; Sourvinos G; Castanas E
    Pharmacol Res Perspect; 2021 Aug; 9(4):e00798. PubMed ID: 34128351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-chain polyphosphates impair SARS-CoV-2 infection and replication.
    Ferrucci V; Kong DY; Asadzadeh F; Marrone L; Boccia A; Siciliano R; Criscuolo G; Anastasio C; Quarantelli F; Comegna M; Pisano I; Passariello M; Iacobucci I; Monica RD; Izzo B; Cerino P; Fusco G; Viscardi M; Brandi S; Pierri BM; Borriello G; Tiberio C; Atripaldi L; Bianchi M; Paolella G; Capoluongo E; Castaldo G; Chiariotti L; Monti M; De Lorenzo C; Yun KS; Pascarella S; Cheong JH; Kim HY; Zollo M
    Sci Signal; 2021 Jul; 14(690):. PubMed ID: 34230209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMU-838, a Developmental DHODH Inhibitor in Phase II for Autoimmune Disease, Shows Anti-SARS-CoV-2 and Broad-Spectrum Antiviral Efficacy In Vitro.
    Hahn F; Wangen C; Häge S; Peter AS; Dobler G; Hurst B; Julander J; Fuchs J; Ruzsics Z; Überla K; Jäck HM; Ptak R; Muehler A; Gröppel M; Vitt D; Peelen E; Kohlhof H; Marschall M
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33291455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome-wide mapping of SARS-CoV-2 RNA structures identifies therapeutically-relevant elements.
    Manfredonia I; Nithin C; Ponce-Salvatierra A; Ghosh P; Wirecki TK; Marinus T; Ogando NS; Snijder EJ; van Hemert MJ; Bujnicki JM; Incarnato D
    Nucleic Acids Res; 2020 Dec; 48(22):12436-12452. PubMed ID: 33166999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the SARS-CoV-2 ExoN (nsp14ExoN-nsp10) complex: implications for its role in viral genome stability and inhibitor identification.
    Baddock HT; Brolih S; Yosaatmadja Y; Ratnaweera M; Bielinski M; Swift LP; Cruz-Migoni A; Fan H; Keown JR; Walker AP; Morris GM; Grimes JM; Fodor E; Schofield CJ; Gileadi O; McHugh PJ
    Nucleic Acids Res; 2022 Feb; 50(3):1484-1500. PubMed ID: 35037045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
    Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
    Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent toxic effects of Taroxaz-104 on the replication of SARS-CoV-2 particles.
    Rabie AM
    Chem Biol Interact; 2021 Jul; 343():109480. PubMed ID: 33887223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers.
    Rosenke K; Leventhal S; Moulton HM; Hatlevig S; Hawman D; Feldmann H; Stein DA
    J Antimicrob Chemother; 2021 Jan; 76(2):413-417. PubMed ID: 33164048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the Conserved Stem Loop 2 Motif in the SARS-CoV-2 Genome.
    Lulla V; Wandel MP; Bandyra KJ; Ulferts R; Wu M; Dendooven T; Yang X; Doyle N; Oerum S; Beale R; O'Rourke SM; Randow F; Maier HJ; Scott W; Ding Y; Firth AE; Bloznelyte K; Luisi BF
    J Virol; 2021 Jun; 95(14):e0066321. PubMed ID: 33963053
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Liu H; Ye F; Sun Q; Liang H; Li C; Li S; Lu R; Huang B; Tan W; Lai L
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):497-503. PubMed ID: 33491508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro.
    Varghese FS; van Woudenbergh E; Overheul GJ; Eleveld MJ; Kurver L; van Heerbeek N; van Laarhoven A; Miesen P; den Hartog G; de Jonge MI; van Rij RP
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33670363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artemisia annua L. extracts inhibit the in vitro replication of SARS-CoV-2 and two of its variants.
    Nair MS; Huang Y; Fidock DA; Polyak SJ; Wagoner J; Towler MJ; Weathers PJ
    J Ethnopharmacol; 2021 Jun; 274():114016. PubMed ID: 33716085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.